TrialThe Lancet. Child & adolescent health2022

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.

Louise F Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.